首页> 外国专利> PET radiopharmaceuticals for the differential diagnosis of a bilateral state and unilateral state of primary hyperaldosteronism

PET radiopharmaceuticals for the differential diagnosis of a bilateral state and unilateral state of primary hyperaldosteronism

机译:PET放射性药物可鉴别诊断原发性醛固酮增多症的双侧状态和单侧状态

摘要

A step of introducing to a mammal having adrenal, selectively binds to CYP11B2 (aldosterone synthase) than (1) CYP11B1 (11β- hydroxylase) and CYP11B2 (aldosterone synthase) inhibitors radiolabeled ( including the step of performing positron emission tomography (PET) in the adrenal region in order to obtain functional PET images of 2) adrenal gland, the functional PET imaging methods for differential with unilateral adenoma and bilateral hyperplasia disclose. Furthermore, the radioactive tracer compounds suitable for use in this method, the precursor for making it, performed by one-pot reaction and rapid is also disclosed a method for manufacturing a can the radiotracer compound.
机译:引入具有肾上腺的哺乳动物的步骤比(1)放射性标记的CYP11B1(11β-羟化酶)和CYP11B2(醛固酮合酶)抑制剂选择性结合CYP11B2(醛固酮合酶)(包括在肾上腺中进行正电子发射断层显像(PET)的步骤)为了获得2)肾上腺的功能性PET图像,公开了用于区分单侧腺瘤和双侧增生的功能性PET成像方法。此外,还公开了通过一锅法快速进行的,适用于该方法的放射性示踪剂化合物,用于制造该放射性示踪剂的前体的制造罐装放射性示踪剂化合物的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号